• Explore /
  • Poster
  • / Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC).

Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC).

Abstract Poster

Authors

null

Dimitrios Ziogas

Department of Oncology, King's College Hospital, London, United Kingdom

Dimitrios Ziogas , Kiruthikah Thillai , Ippokratis Korantzis , MH Ruhe Chowdhury , Dionysios Papadatos-Pastos , Abid Suddle , John O'Grady , Nigel Heaton , Paul J. Ross , Debashis Sarker

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 435)

DOI

10.1200/jco.2015.33.3_suppl.435

Abstract #

435

Poster Bd #

E2

Abstract Disclosures

Similar Posters

First Author: Swetha Kambhampati

First Author: Timothy J. Brown

First Author: Kazufumi Kobayashi

First Author: William Joseph Chapin